BioMarin Pharmaceutical Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy BioMarin Pharmaceutical Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell BioMarin Pharmaceutical Inc. stocks after a simple registration process. </div>

Q: How to buy BioMarin Pharmaceutical Inc. shares in India?

<div> To buy BioMarin Pharmaceutical Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for BioMarin Pharmaceutical Inc. and you are done!</div> </div>

Q: What is the share price of BioMarin Pharmaceutical Inc.?

<div>The share price of BioMarin Pharmaceutical Inc. is USD 83.8 as on 2 May.</div>

Q: What is the Market Capitalization of BioMarin Pharmaceutical Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of BioMarin Pharmaceutical Inc. is USD 15.91B as on 2 May.</div>

Q: What is the PE ratio of BioMarin Pharmaceutical Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of BioMarin Pharmaceutical Inc. is 77.01 as on 2 May. </div>

Q: Is BioMarin Pharmaceutical Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of BioMarin Pharmaceutical Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does BioMarin Pharmaceutical Inc. operate?

<div> BioMarin Pharmaceutical Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$83.8

+0.47

(2 May)

Loading Chart

Previous close

$83.80

Open

$83.80

Today’s high

$85.03

Today’s low

$81.43

52W low

$76.02

52W high

$99.56

-10.65%

0.11%

77.01

EPS (TTM)

1.07

Shares O/S

189.88M

Market cap

15.91B

Insights

BMRN price is below its 200 day moving average

BMRN PE is in the low end of its range over the past 2 years

BMRN PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.

In beta. Send feedback here.

Compare with other stock

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide).

Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease. .

FAQs

Can I buy BioMarin Pharmaceutical Inc. shares in India?

How to buy BioMarin Pharmaceutical Inc. shares in India?

What is the share price of BioMarin Pharmaceutical Inc.?

What is the Market Capitalization of BioMarin Pharmaceutical Inc.?

What is the PE ratio of BioMarin Pharmaceutical Inc.?

Is BioMarin Pharmaceutical Inc. a good stock to buy?

In which sector / industry does BioMarin Pharmaceutical Inc. operate?